Kenvue forecast its annual profit below Wall Street estimates and largely met quarterly earnings expectations on Thursday, amid a strategic review at the consumer health company.
The Band-Aid maker in July had ousted its CEO Thibaut Mongon, a move that some investors said could lay the groundwork for an eventual sale of the entire company or pieces of it.
The company had then said it created a committee, advised by investment bank Centerview Partners and consulting firm McKinsey, to weigh…

